Skip to main content
NCBI home page
Sexually Transmitted Infections logoLink to Sexually Transmitted Infections
. 1999 Aug;75(4):253–257. doi: 10.1136/sti.75.4.253

Association of human papillomavirus with HIV and CD4 cell count in women with high or low numbers of sex partners

M A Piper, S T Severin, S Z Wiktor, E R Unger, P D Ghys, D L Miller, I R Horowitz, A E Greenberg, W C Reeves, S D Vernon
PMCID: PMC1758229  PMID: 10615312

Abstract

OBJECTIVE: To explore whether HIV serostatus (HIV-1, HIV-2, and dual (HIV-D) reactivity) and CD4 cell count affect human papillomavirus (HPV) in two groups of women from Cote d'Ivoire. METHODS: We conducted a cross sectional study of two groups of women. One group had low numbers of lifetime sex partners (maternal women, n = 258) and were enrolled based on HIV serostatus. The other group had high numbers of sex partners (female sex workers, n = 278) and all consenting self identified sex workers were admitted to this study. We collected epidemiological and clinical data, and cervicovaginal lavage for HPV testing. RESULTS: The groups had different distributions of HIV seroreactivity, but the rates of HPV DNA detection were similar. Most of the HPV DNAs detected in both groups were high risk types. A strong association of high risk HPV DNA and HIV-1 seropositivity was found in both maternal women (adjusted odds ratio (OR) 7.5 (95% CI 3.2-17.4)) and in sex workers (OR 5.0 (2.1-12.0)). The maternal group also showed an association of high risk HPV DNA detection with HIV-2 (OR 3.7 (1.6-8.5)) and HIV-D (OR 12.7 (4.3-37.5)) that was not observed in the sex workers. In addition, the association of high risk HPV DNA with HIV-1 in the maternal group was independent of low CD4 cell count, while in the sex workers the association depended on CD4 cell counts < or = 500 x 10(6)/l. CONCLUSIONS: We found that an association between HPV and HIV varied depending on the sexual behaviour and CD4 cell count of the population examined. 




Full Text

The Full Text of this article is available as a PDF (75.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adjorlolo-Johnson G., De Cock K. M., Ekpini E., Vetter K. M., Sibailly T., Brattegaard K., Yavo D., Doorly R., Whitaker J. P., Kestens L. Prospective comparison of mother-to-child transmission of HIV-1 and HIV-2 in Abidjan, Ivory Coast. JAMA. 1994 Aug 10;272(6):462–466. [PubMed] [Google Scholar]
  2. Buonaguro F. M., Tornesello M. L., Buonaguro L., Del Gaudio E., Beth-Giraldo E., Giraldo G. Role of HIV as cofactor in HPV oncogenesis: in vitro evidences of virus interactions. Antibiot Chemother (1971) 1994;46:102–109. doi: 10.1159/000423637. [DOI] [PubMed] [Google Scholar]
  3. De Cock K. M., Adjorlolo G., Ekpini E., Sibailly T., Kouadio J., Maran M., Brattegaard K., Vetter K. M., Doorly R., Gayle H. D. Epidemiology and transmission of HIV-2. Why there is no HIV-2 pandemic. JAMA. 1993 Nov 3;270(17):2083–2086. doi: 10.1001/jama.270.17.2083. [DOI] [PubMed] [Google Scholar]
  4. De Cock K. M., Porter A., Kouadio J., Maran M., Gnaore E., Adjorlolo G., Lafontaine M. F., Bretton G., Damet G. M., Odehouri K. Rapid and specific diagnosis of HIV-1 and HIV-2 infections: an evaluation of testing strategies. AIDS. 1990 Sep;4(9):875–878. doi: 10.1097/00002030-199009000-00007. [DOI] [PubMed] [Google Scholar]
  5. Feingold A. R., Vermund S. H., Burk R. D., Kelley K. F., Schrager L. K., Schreiber K., Munk G., Friedland G. H., Klein R. S. Cervical cytologic abnormalities and papillomavirus in women infected with human immunodeficiency virus. J Acquir Immune Defic Syndr. 1990;3(9):896–903. [PubMed] [Google Scholar]
  6. Ferrera A., Melchers W. J., Velema J. P., Figueroa M. Association of infections with human immunodeficiency virus and human papillomavirus in Honduras. Am J Trop Med Hyg. 1997 Aug;57(2):138–141. doi: 10.4269/ajtmh.1997.57.138. [DOI] [PubMed] [Google Scholar]
  7. George J. R., Ou C. Y., Parekh B., Brattegaard K., Brown V., Boateng E., De Cock K. M. Prevalence of HIV-1 and HIV-2 mixed infections in Côte d'Ivoire. Lancet. 1992 Aug 8;340(8815):337–339. doi: 10.1016/0140-6736(92)91406-x. [DOI] [PubMed] [Google Scholar]
  8. Ghys P. D., Diallo M. O., Ettiègne-Traoré V., Yeboué K. M., Gnaoré E., Lorougnon F., Kalé K., Van Dyck E., Brettegaard K., Hoyi Y. M. Genital ulcers associated with human immunodeficiency virus-related immunosuppression in female sex workers in Abidjan, Ivory Coast. J Infect Dis. 1995 Nov;172(5):1371–1374. doi: 10.1093/infdis/172.5.1371. [DOI] [PubMed] [Google Scholar]
  9. Ho G. Y., Burk R. D., Fleming I., Klein R. S. Risk of genital human papillomavirus infection in women with human immunodeficiency virus-induced immunosuppression. Int J Cancer. 1994 Mar 15;56(6):788–792. doi: 10.1002/ijc.2910560605. [DOI] [PubMed] [Google Scholar]
  10. Johnson J. C., Burnett A. F., Willet G. D., Young M. A., Doniger J. High frequency of latent and clinical human papillomavirus cervical infections in immunocompromised human immunodeficiency virus-infected women. Obstet Gynecol. 1992 Mar;79(3):321–327. doi: 10.1097/00006250-199203000-00001. [DOI] [PubMed] [Google Scholar]
  11. Kjaer S. K., van den Brule A. J., Bock J. E., Poll P. A., Engholm G., Sherman M. E., Walboomers J. M., Meijer C. J. Determinants for genital human papillomavirus (HPV) infection in 1000 randomly chosen young Danish women with normal Pap smear: are there different risk profiles for oncogenic and nononcogenic HPV types? Cancer Epidemiol Biomarkers Prev. 1997 Oct;6(10):799–805. [PubMed] [Google Scholar]
  12. Kreiss J. K., Kiviat N. B., Plummer F. A., Roberts P. L., Waiyaki P., Ngugi E., Holmes K. K. Human immunodeficiency virus, human papillomavirus, and cervical intraepithelial neoplasia in Nairobi prostitutes. Sex Transm Dis. 1992 Jan-Feb;19(1):54–59. doi: 10.1097/00007435-199201000-00011. [DOI] [PubMed] [Google Scholar]
  13. Laga M., Icenogle J. P., Marsella R., Manoka A. T., Nzila N., Ryder R. W., Vermund S. H., Heyward W. L., Nelson A., Reeves W. C. Genital papillomavirus infection and cervical dysplasia--opportunistic complications of HIV infection. Int J Cancer. 1992 Jan 2;50(1):45–48. doi: 10.1002/ijc.2910500110. [DOI] [PubMed] [Google Scholar]
  14. Langley C. L., Benga-De E., Critchlow C. W., Ndoye I., Mbengue-Ly M. D., Kuypers J., Woto-Gaye G., Mboup S., Bergeron C., Holmes K. K. HIV-1, HIV-2, human papillomavirus infection and cervical neoplasia in high-risk African women. AIDS. 1996 Apr;10(4):413–417. doi: 10.1097/00002030-199604000-00010. [DOI] [PubMed] [Google Scholar]
  15. Marlink R., Kanki P., Thior I., Travers K., Eisen G., Siby T., Traore I., Hsieh C. C., Dia M. C., Gueye E. H. Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science. 1994 Sep 9;265(5178):1587–1590. doi: 10.1126/science.7915856. [DOI] [PubMed] [Google Scholar]
  16. Penn I. Cancers of the anogenital region in renal transplant recipients. Analysis of 65 cases. Cancer. 1986 Aug 1;58(3):611–616. doi: 10.1002/1097-0142(19860801)58:3<611::aid-cncr2820580303>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  17. Seck A. C., Faye M. A., Critchlow C. W., Mbaye A. D., Kuypers J., Woto-Gaye G., Langley C., De E. B., Holmes K. K., Kiviat N. B. Cervical intraepithelial neoplasia and human papillomavirus infection among Senegalese women seropositive for HIV-1 or HIV-2 or seronegative for HIV. Int J STD AIDS. 1994 May-Jun;5(3):189–193. doi: 10.1177/095646249400500307. [DOI] [PubMed] [Google Scholar]
  18. Sun X. W., Ellerbrock T. V., Lungu O., Chiasson M. A., Bush T. J., Wright T. C., Jr Human papillomavirus infection in human immunodeficiency virus-seropositive women. Obstet Gynecol. 1995 May;85(5 Pt 1):680–686. doi: 10.1016/0029-7844(95)00025-m. [DOI] [PubMed] [Google Scholar]
  19. Sun X. W., Kuhn L., Ellerbrock T. V., Chiasson M. A., Bush T. J., Wright T. C., Jr Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med. 1997 Nov 6;337(19):1343–1349. doi: 10.1056/NEJM199711063371903. [DOI] [PubMed] [Google Scholar]
  20. Svare E. I., Kjaer S. K., Worm A. M., Osterlind A., Moi H., Christensen R. B., Meijer C. J., Walboomers J. M., van den Brule A. J. Risk factors for HPV infection in women from sexually transmitted disease clinics: comparison between two areas with different cervical cancer incidence. Int J Cancer. 1998 Jan 5;75(1):1–8. doi: 10.1002/(sici)1097-0215(19980105)75:1<1::aid-ijc1>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  21. Van Doornum G. J., Van den Hoek J. A., Van Ameijden E. J., Van Haastrecht H. J., Roos M. T., Henquet C. J., Quint W. G., Coutinho R. A. Cervical HPV infection among HIV-infected prostitutes addicted to hard drugs. J Med Virol. 1993 Nov;41(3):185–190. doi: 10.1002/jmv.1890410303. [DOI] [PubMed] [Google Scholar]
  22. Vernon S. D., Hart C. E., Reeves W. C., Icenogle J. P. The HIV-1 tat protein enhances E2-dependent human papillomavirus 16 transcription. Virus Res. 1993 Feb;27(2):133–145. doi: 10.1016/0168-1702(93)90077-z. [DOI] [PubMed] [Google Scholar]
  23. Vernon S. D., Holmes K. K., Reeves W. C. Human papillomavirus infection and associated disease in persons infected with human immunodeficiency virus. Clin Infect Dis. 1995 Aug;21 (Suppl 1):S121–S124. doi: 10.1093/clinids/21.supplement_1.s121. [DOI] [PubMed] [Google Scholar]
  24. Vernon S. D., Reeves W. C., Clancy K. A., Laga M., St Louis M., Gary H. E., Jr, Ryder R. W., Manoka A. T., Icenogle J. P. A longitudinal study of human papillomavirus DNA detection in human immunodeficiency virus type 1-seropositive and -seronegative women. J Infect Dis. 1994 May;169(5):1108–1112. doi: 10.1093/infdis/169.5.1108. [DOI] [PubMed] [Google Scholar]
  25. Vernon S. D., Unger E. R., Piper M. A., Severin S. T., Wiktor S. Z., Ghys P. D., Miller D. L., Horowitz I. R., Greenberg A. E., Reeves W. C. HIV and human papillomavirus as independent risk factors for cervical neoplasia in women with high or low numbers of sex partners. Sex Transm Infect. 1999 Aug;75(4):258–260. doi: 10.1136/sti.75.4.258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. ter Meulen J., Eberhardt H. C., Luande J., Mgaya H. N., Chang-Claude J., Mtiro H., Mhina M., Kashaija P., Ockert S., Yu X. Human papillomavirus (HPV) infection, HIV infection and cervical cancer in Tanzania, east Africa. Int J Cancer. 1992 Jun 19;51(4):515–521. doi: 10.1002/ijc.2910510403. [DOI] [PubMed] [Google Scholar]

Articles from Sexually Transmitted Infections are provided here courtesy of BMJ Publishing Group

RESOURCES